Hólyagrák: vizsgálatok itt: Norvégia
9 of 12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Lørenskog, Oslo
- Életkor
- 18 év and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisBefejeződöttA Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Where
- Loerenskog
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07222488 · EU 2025-520467-40-00 - 1. fázisTaking peopleFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05614739 · EU 2022-502755-59-00 - 2/3. fázisNot yet taking people in NorvégiaDato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
- Where
- Loerenskog, Stavanger, Toensberg
- Életkor
- 18 év and over
- People
- 343 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00 - 2. fázisNot yet taking people in NorvégiaFeasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma
- Where
- Bergen
- Életkor
- 18 év and over
- People
- 196 worldwide
- Run by
- European Uro-Oncology Group Stichting
See details and how to joinNCT02969083 · EU 2024-514991-41-01 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Lørenskog, Sarpsborg, Tønsberg
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Bergen, Oslo
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 4. fázisTaking peopleChemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer
- Where
- Bergen, Toensberg
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aarhus University
See details and how to join2022-502221-18-00 - 4. fázisNot yet taking people in NorvégiaChemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
- Where
- Bergen, Tønsberg
- Életkor
- 18 év and over
- People
- 272 worldwide
- Run by
- Jakob Kristian Jakobsen
See details and how to joinNCT06781879